Cargando…
ETMR-01. TREATMENT OUTCOME OF TWO CASES WITH HIGH-GRADE NEUROEPITHELIAL TUMOR WITH BCOR ALTERATION
INTRODUCTION: High grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication (HGNET BCOR) is a recently described tumor entity of the central nervous system (CNS) with a distinct methylation profile and characteristic genetic alteration. We report the outcome of two cases after 1(st)...
Autores principales: | Kristensen, Ines, Hansen, Louise Lindholt, Mikkelsen, Torben Stamm, Henriksen, Louise Tram, Parm Uldhøi, Benedicte, von Oettingen, Gorm, Cortnum, Søren, Lassen-Ramshad, Yasmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715717/ http://dx.doi.org/10.1093/neuonc/noaa222.205 |
Ejemplares similares
-
ETMR-03. Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022) -
ETMR-01. Management of CNS tumor with BCOR internal tandem duplication with multimodalities therapy: Surgery, Intensive Chemotherapy, and Radiation
por: Mobark, Nahla Ali, et al.
Publicado: (2022) -
ETMR-11. Transcriptional changes upon knockdown of alteredBCOR/BCORL1 transcripts in preclinical models of CNS embryonal tumors with BCOR-related alterations
por: Piontek, Martin, et al.
Publicado: (2022) -
ETMR-06. Molecular and clinical characteristics of CNS tumors withBCOR(L1) fusion/internal tandem duplication
por: Gojo, Johannes, et al.
Publicado: (2022) -
ETMR-12. Novel cell models of CNS tumors with BCOR fusion or internal tandem duplication suggest FGFR and PDGFR as promising therapy targets
por: Kirchhofer, Dominik, et al.
Publicado: (2022)